Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial.
暂无分享，去创建一个
K. Brock | Y. Summers | G. Middleton | L. Billingham | C. Ottensmeier | S. Popat | R. Shah | J. Savage | G. Barone | R. Mant | J. Connibear | P. Shaw | S. Ming-Lee | C. Barrie | Gary Middleton | Christian H. Ottensmeier | Rhys Mant | S. Popat | Kristian Brock | Y. Summers | Lucinda J. Billingham